Futura's innovation strategy applies advanced science to develop products with compelling commercial potential using our advanced proprietary transdermal technology.
Based in Surrey, UK, the company's shares trade on the AIM market of the London Stock Exchange. Futura's development pipeline focuses on sexual healthcare and pain relief management and we are evaluating further therapeutic opportunities as potential additions to the pipeline. Futura is gaining recognition within the pharmaceutical industry for its strengths in transdermal drug delivery technology. We have a number of relationships with key players.
Futura Medical was founded in 1997 and is headquartered in Guildford, GB
Key People at Futura Medical
Futura Medical Locations
Futura Medical Metrics
Futura Medical Summary
Closing share price
Futura Medical's current market capitalization is £58.7 M.
Futura Medical Financials
We estimate that Futura Medical's revenue is £29.5 K in FY, 2015 which is 32.9% decrease from the previous period.